Most Accessed Articles

Estimating Alzheimer’s Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia

, 2018; 15(8): 777-788.

Matthew Davis, Thomas O`Connell, Scott Johnson, Stephanie Cline*, Elizabeth Merikle, Ferenc Martenyi and Kit Simpson

DOI: 10.2174/1567205015666180119092427

Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer's Disease

, 2015; 12(1): 32-46.

Robert J. Baranello, Krishna L. Bharani, Vasudevaraju Padmaraju, Nipun Chopra, Debomoy K. Lahiri, Nigel H. Greig, Miguel A. Pappolla and Kumar Sambamurti

DOI: 10.2174/1567205012666141218140953

Auditory Event-related Potentials in Mild Cognitive Impairment and Alzheimer’s Disease

, 2018; 15(8): 702-715.

Cassandra Morrison*, Sheida Rabipour, Frank Knoefel, Christine Sheppard and Vanessa Taler

DOI: 10.2174/1567205015666180123123209

Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

, 2008; 5(1): 83-89.

Anton P. Porsteinsson, George T. Grossberg, Jacobo Mintzer and Jason T. Olin

DOI: 10.2174/156720508783884576

Technological Solutions for Older People with Alzheimer’s Disease: Review

, 2018; 15(10): 975-983.

Petra Maresova*, Signe Tomsone, Petre Lameski, Joana Madureira, Ana Mendes, Eftim Zdravevski, Ivan Chorbev, Vladimir Trajkovik, Moriah Ellen and Kasper Rodile

DOI: 10.2174/1567205015666180427124547

Tau Positive Neurons Show Marked Mitochondrial Loss and Nuclear Degradation in Alzheimer's Disease

, 2018; 15(10): 928-937.

Melissa Wee, Fariba Chegini, John H.T. Power* and Shohreh Majd

DOI: 10.2174/1567205015666180613115644

Webmaster Contact:
Copyright © 2018 Bentham Science